Side Effects of Mounjaro UK - Complete Safety Guide 2025

Clinically Proven UK Registered Pharmacy

Side Effects of Mounjaro - Cheapest UK Price £124.99

Learn about Mounjaro at the cheapest UK price from £124.99 with £20 off using code Weightlossnew.

UK-registered clinical team
Confidential and secure
No GP visit needed
Fast and discreet delivery
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

Weightlossnew £20 off for new customers
Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for weight loss treatment
£145.00 From £124.99 £20 discount using discount code Weightlossnew
LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Mounjaro (Tirzepatide)
Weeks 1–4

2.5mg

1 pen • 4 Weeks

£145 £124.99

£31.25 / Per Week

Your starting dose – designed to help your body adjust gently to treatment

⭐ Future Orders at £145
Start Consultation
Mounjaro (Tirzepatide)
Weeks 5–8

5mg

1 pen • 4 Weeks

£179 £159.00

£39.75 / Per Week

First step up – builds on your progress as your body adapts to treatment

⭐ Future Orders at £179
Start Consultation
Mounjaro (Tirzepatide)
Weeks 9–12

7.5mg

1 pen • 4 Weeks

£220 £200.00

£50.00 / Per Week

Mid-range dose – for continued progression and enhanced results

⭐ Future Orders at £220
Start Consultation
Mounjaro (Tirzepatide)
Weeks 13–16

10mg

1 pen • 4 Weeks

£245 £225.00

£56.25 / Per Week

Higher strength dose – supports significant weight loss progress

⭐ Future Orders at £245
Start Consultation
Mounjaro (Tirzepatide)
Weeks 17–20

12.5mg

1 pen • 4 Weeks

£270 £250.00

£62.50 / Per Week

Advanced dose – for patients requiring stronger therapeutic effect

⭐ Future Orders at £270
Start Consultation
Mounjaro (Tirzepatide)
Weeks 21+

15mg

1 pen • 4 Weeks

£287 £267.00

£66.75 / Per Week

Maximum dose – the highest available strength for optimal results

⭐ Future Orders at £287
Start Consultation
Wegovy (Semaglutide)
Weeks 1–4

0.25mg

1 pen • 4 Weeks

£89 £69.00

£17.25 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £89
Start Consultation
Wegovy (Semaglutide)
Weeks 5–8

0.5mg

1 pen • 4 Weeks

£109 £89.00

£22.25 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £109
Start Consultation
Wegovy (Semaglutide)
Weeks 9–12

1mg

1 pen • 4 Weeks

£119 £99.00

£24.75 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £119
Start Consultation
Wegovy (Semaglutide)
Weeks 13–16

1.7mg

1 pen • 4 Weeks

£169 £149.00

£37.25 / Per Week

Higher strength – supports accelerated weight loss progress

⭐ Future Orders at £169
Start Consultation
Wegovy (Semaglutide)
Weeks 17+

2.4mg

1 pen • 4 Weeks

£199 £179.00

£44.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199
Start Consultation
Wegovy (Oral Pill)
Weeks 1–4

1.5mg

1 pen • 4 Weeks

£83.00

£20.75 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

Start Consultation
Wegovy (Oral Pill)
Weeks 5–8

4mg

1 pen • 4 Weeks

£110.00

£27.50 / Per Week

First step up – continues building tolerance for long-term success

Start Consultation
Wegovy (Oral Pill)
Weeks 9–12

9mg

1 pen • 4 Weeks

£140.00

£35.00 / Per Week

Mid-range dose – where most patients start seeing meaningful results

Start Consultation
Wegovy (Oral Pill)
Weeks 13+

25mg

1 pen • 4 Weeks

£199.00

£49.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

Start Consultation

Side Effects of Mounjaro: Complete UK Clinical Guide

Understanding the side effects of Mounjaro (tirzepatide) is essential before starting this prescription weight loss treatment. As a UK-registered pharmacy with thousands of patients supported through their weight management journey, we provide evidence-based guidance on what to expect, how to manage reactions, and when clinical intervention is needed. Mounjaro is available from £124.99 at Cured Pharmacy, subject to prescriber approval following online clinical assessment.

Common Side Effects of Mounjaro: What UK Patients Experience

The most frequently reported side effects of Mounjaro affect the gastrointestinal system, particularly during the initial weeks of treatment. In the SURPASS clinical trial programme, nausea occurred in approximately 22-29% of participants, diarrhoea in 19-23%, and vomiting in 9-13% across different dose strengths[1]. These reactions typically emerge within the first four weeks and diminish as the body adapts to tirzepatide.

Other common side effects of Mounjaro include decreased appetite (which contributes to weight loss efficacy), constipation affecting around 7-11% of users, and mild abdominal discomfort[1]. Injection site reactions such as redness, itching, or swelling occur in fewer than 5% of patients and usually resolve within 48 hours. Fatigue and headache are reported occasionally, particularly when dose escalation occurs too rapidly without adequate hydration.

Understanding that these side effects of Mounjaro are generally transient helps patients maintain treatment adherence. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) advises that most gastrointestinal symptoms can be effectively managed through dietary modifications, slower eating pace, and avoiding high-fat meals during the adjustment period. Patients who experience persistent or worsening symptoms beyond four weeks should contact their prescriber for dose review.

Gastrointestinal Side Effects: Severity and Duration

Nausea represents the most common gastrointestinal side effect of Mounjaro, with peak incidence typically occurring 2-4 days after injection. Clinical data shows that severity is dose-dependent, with higher maintenance doses (10mg and 15mg) associated with slightly increased rates compared to starter doses[1]. Most patients describe nausea as mild to moderate, rarely requiring antiemetic medication. Eating smaller, more frequent meals and avoiding triggers like spicy or fatty foods significantly reduces symptom intensity.

Diarrhoea associated with Mounjaro usually manifests as loose stools rather than severe watery diarrhoea. Episodes tend to be self-limiting, lasting 24-72 hours after injection. Maintaining adequate hydration is critical, particularly for patients taking concurrent medications affected by fluid balance. Constipation, conversely, may develop in the second or third month of treatment and responds well to increased dietary fibre and water intake. These side effects of Mounjaro rarely necessitate treatment discontinuation when appropriate management strategies are employed.

Serious Side Effects of Mounjaro: Warning Signs and Action Required

While uncommon, certain serious side effects of Mounjaro require immediate medical attention. Acute pancreatitis, though rare (occurring in less than 0.2% of clinical trial participants), presents with severe persistent abdominal pain radiating to the back, often accompanied by nausea and vomiting[2]. The MHRA advises discontinuing tirzepatide immediately if pancreatitis is suspected and seeking urgent medical assessment.

Gallbladder complications including cholecystitis and cholelithiasis have been reported in weight loss medication trials, with rapid weight reduction being a contributing factor. Symptoms include sharp right upper abdominal pain, particularly after meals, fever, and jaundice. Severe allergic reactions (anaphylaxis) to Mounjaro are extremely rare but constitute a medical emergency—symptoms include difficulty breathing, facial swelling, rapid pulse, and widespread rash[2].

Hypoglycaemia represents another potentially serious side effect of Mounjaro, particularly when used alongside sulfonylureas or insulin. Symptoms include trembling, confusion, sweating, rapid heartbeat, and dizziness. Patients combining tirzepatide with other glucose-lowering medications require dose adjustments of concurrent therapies to minimise this risk. Vision changes, persistent vomiting preventing fluid intake, and signs of kidney problems (reduced urination, swelling) also warrant prompt clinical review.

Managing Side Effects of Mounjaro: Practical UK Pharmacist Strategies

Effective management of side effects of Mounjaro begins with appropriate dose titration. The recommended UK starting dose is 2.5mg weekly for four weeks, serving as a tolerability-building phase rather than a therapeutic dose. Escalating too quickly to higher doses significantly increases gastrointestinal side effects. Our clinical team at Cured Pharmacy provides personalised dose progression guidance based on individual tolerance and response.

Dietary modifications substantially reduce nausea and digestive discomfort. Patients should avoid large meals, instead consuming smaller portions every 3-4 hours. High-fat and heavily processed foods delay gastric emptying, exacerbating Mounjaro's natural effect on digestion. Ginger tea, peppermint, and bland carbohydrates like crackers or toast help settle nausea. Timing injections before bedtime allows patients to sleep through peak nausea periods, typically occurring 12-24 hours post-injection.

Hydration is critical for managing side effects of Mounjaro, particularly when experiencing diarrhoea or reduced appetite. Aim for 2-2.5 litres of water daily, sipping gradually rather than consuming large volumes at once. Electrolyte solutions may benefit patients with persistent loose stools. Injection technique also matters—rotating injection sites between abdomen, thigh, and upper arm prevents localised reactions, and allowing the pen to reach room temperature before injecting reduces discomfort.

When to Contact Your Prescriber About Side Effects

Certain side effects of Mounjaro warrant prescriber consultation even if not classified as medical emergencies. Persistent vomiting lasting more than 24 hours, inability to keep fluids down, or signs of dehydration (dark urine, dizziness upon standing, dry mouth) require clinical review for potential dose adjustment or temporary treatment pause. Unexplained weight loss exceeding 1.5kg per week may indicate excessive medication effect.

New or worsening abdominal pain that differs from initial mild discomfort, particularly if localised to specific areas, should be assessed to rule out pancreatitis or gallbladder issues. Changes in bowel habits persisting beyond four weeks, blood in stools, or severe constipation unresponsive to dietary measures need evaluation. Mood changes, including persistent low mood or anxiety, though not directly caused by tirzepatide, may relate to rapid lifestyle changes and benefit from clinical support. Our UK-registered prescribers at Cured Pharmacy are available for medication reviews throughout your treatment journey.

Treatment Primary Side Effects Injection Frequency Starting Price
Mounjaro (Tirzepatide) Nausea, diarrhoea, decreased appetite Weekly From £145.00
Wegovy (Semaglutide) Nausea, vomiting, constipation Weekly From £89.00
Saxenda (Liraglutide) Nausea, diarrhoea, headache Daily From £68.00
Orlistat Oily stools, flatulence, urgency Oral (3x daily) From £32.00

Long-Term Side Effects of Mounjaro: What Clinical Trials Show

Long-term safety data from the SURPASS trials, with some participants followed for up to 52 weeks, demonstrates that side effects of Mounjaro generally decrease in frequency and severity after the initial 12-16 weeks[3]. Gastrointestinal symptoms, which peak during dose escalation, typically resolve or become manageable as patients reach their maintenance dose. Discontinuation rates due to adverse effects were approximately 6-8% across trials, lower than some alternative weight loss medications.

Extended monitoring has not revealed unexpected safety signals with prolonged tirzepatide use. Thyroid C-cell tumours, observed in rodent studies, have not been confirmed in human populations, though Mounjaro remains contraindicated for patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2[3]. Regular clinical monitoring, including periodic assessment of kidney function and gallbladder health in high-risk patients, forms part of responsible long-term prescribing.

Patients maintained on Mounjaro for extended periods report improved tolerance, with many experiencing no ongoing side effects after the initial adjustment phase. Weight maintenance and metabolic improvements continue throughout treatment duration, with cardiovascular benefits emerging in longer-term studies. Understanding that side effects of Mounjaro are predominantly early-phase phenomena helps patients maintain realistic expectations and treatment adherence. The UK clinical guidance recommends regular prescriber reviews every 3-6 months to assess ongoing suitability and efficacy.

Comparing Side Effects of Mounjaro with Alternative Weight Loss Treatments

When evaluating side effects of Mounjaro against alternatives like semaglutide (Wegovy) or liraglutide (Saxenda), the overall safety profile shows similarities with some notable differences. Tirzepatide's dual GIP/GLP-1 receptor agonism produces comparable gastrointestinal side effects to semaglutide, though some studies suggest slightly lower nausea rates with Mounjaro at equivalent weight loss efficacy[4]. Both medications share similar contraindications and require identical precautions regarding pancreatitis and thyroid risks.

Compared to Saxenda (liraglutide), which requires daily injections, Mounjaro's weekly dosing schedule may improve adherence despite similar side effect profiles. Orlistat, a lipase inhibitor available at Cured Pharmacy from £124.99, produces different side effects primarily related to fat malabsorption—oily stools, flatulence, and faecal urgency—rather than nausea. Patients intolerant of GLP-1 receptor agonist gastrointestinal effects may find orlistat a suitable alternative, though weight loss efficacy differs.

The side effects of Mounjaro must be weighed against its superior efficacy data, with SURPASS-2 demonstrating average weight loss of 12.4kg at the 15mg dose compared to 6.2kg with semaglutide 1mg over 40 weeks[4]. For many patients, the transient nature of initial side effects represents an acceptable trade-off for enhanced weight loss outcomes. Individual tolerance varies significantly, making personalised clinical assessment essential. Our UK prescribers at Cured Pharmacy evaluate medical history, concurrent medications, and patient preferences to recommend the most appropriate treatment option.

Patient Tolerance Factors Affecting Side Effect Experience

Individual variation in experiencing side effects of Mounjaro relates to multiple factors including baseline BMI, age, concurrent medications, and gastrointestinal sensitivity. Patients with pre-existing gastroparesis or irritable bowel syndrome may experience more pronounced digestive symptoms. Those with higher starting BMI sometimes report better tolerance, possibly due to greater metabolic adaptation capacity. Age does not significantly predict side effect severity, though older patients require closer monitoring for dehydration risk.

Genetic factors influencing drug metabolism and receptor sensitivity contribute to the wide range of individual responses. Some patients experience minimal side effects even at maximum doses, while others find lower doses challenging. This variability underscores the importance of individualised dose titration and ongoing clinical communication. Psychological readiness and understanding of expected side effects also improve tolerance—patients who receive comprehensive pre-treatment counselling demonstrate better adherence and symptom management. Cured Pharmacy provides detailed patient information and ongoing support throughout your Mounjaro treatment journey, with prescriber access for concerns.

Side Effects of Mounjaro: UK Regulatory Perspective and Patient Safety

The MHRA granted UK marketing authorisation for Mounjaro in November 2023 following comprehensive safety evaluation. Post-marketing surveillance continues to monitor real-world side effect patterns beyond clinical trial populations. The Yellow Card scheme allows UK patients and healthcare professionals to report suspected side effects of Mounjaro, contributing to ongoing safety assessment. Current MHRA guidance emphasises appropriate patient selection, excluding those with contraindications, and ensuring informed consent regarding potential adverse effects[5].

NICE guidance on tirzepatide for weight management acknowledges the side effect profile while recognising the medication's clinical value when prescribed appropriately. The NHS framework for weight management services requires prescribers to provide detailed counselling about expected side effects, management strategies, and circumstances requiring medical review. As a GPhC-registered pharmacy (9012511), Cured Pharmacy operates within these regulatory frameworks, ensuring all Mounjaro prescriptions follow UK clinical guidelines and safety protocols.

Patient safety mechanisms include mandatory online clinical assessment before prescribing, ongoing prescriber access for side effect management, and clear information about warning signs requiring urgent attention. Understanding side effects of Mounjaro within this regulatory context reassures patients that UK-licensed treatment pathways prioritise safety alongside efficacy. All prescription medications available through Cured Pharmacy, including Mounjaro at £124.99, require approval by our UK-registered prescribers following comprehensive medical assessment. Transparent communication about both benefits and risks enables informed treatment decisions aligned with individual health goals.

Reporting and Monitoring Side Effects in UK Practice

UK patients experiencing side effects of Mounjaro should report them through multiple channels. Direct communication with your prescriber enables dose adjustment or management strategy modification. Serious or unexpected reactions should additionally be reported via the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk), contributing to national pharmacovigilance. This dual reporting ensures both individual care optimisation and broader medication safety monitoring.

Regular follow-up appointments, typically scheduled at 4, 12, and 24 weeks after starting Mounjaro, allow systematic side effect assessment and early intervention if needed. Blood tests monitoring kidney function, liver enzymes, and metabolic markers help detect subclinical effects before symptoms develop. Patient diaries tracking side effects, dietary intake, and weight changes provide valuable information for optimising treatment. At Cured Pharmacy, our clinical team maintains ongoing communication with patients throughout their weight management journey, ensuring side effects are promptly addressed and treatment remains safe and effective.

Scientific References

  1. Rosenstock, J., Wysham, C., Frías, J. P., et al. (2021). Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial. The Lancet, 398(10295), 143-155.
  2. Medicines and Healthcare products Regulatory Agency. (2023). Mounjaro (tirzepatide): Summary of Product Characteristics. MHRA UK Public Assessment Report.
  3. Ludvik, B., Giorgino, F., Jódar, E., et al. (2021). Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial. The Lancet, 398(10300), 583-598.
  4. Frías, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes (SURPASS-2): a randomised, open-label, parallel-group, multicentre, phase 3 trial. The Lancet, 398(10303), 1001-1014.
  5. National Institute for Health and Care Excellence. (2024). Tirzepatide for managing overweight and obesity: Technology appraisal guidance. NICE TA1007.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

How long do side effects of Mounjaro typically last?
Most side effects of Mounjaro, particularly nausea and digestive symptoms, peak during the first 4-8 weeks and significantly diminish as your body adapts. By week 12, the majority of patients report minimal or no ongoing side effects.
Can I take medication to prevent side effects of Mounjaro?
While no preventive medication is routinely recommended, dietary modifications and proper hydration effectively manage most side effects. For persistent nausea, your prescriber may occasionally recommend short-term antiemetics alongside dose adjustment.
Are side effects of Mounjaro worse at higher doses?
Yes, gastrointestinal side effects generally increase with dose escalation, which is why gradual titration starting at 2.5mg is essential. Most patients tolerate higher maintenance doses well after completing the step-up protocol over 12-20 weeks.
What are the most serious side effects of Mounjaro I should watch for?
Severe persistent abdominal pain (possible pancreatitis), allergic reactions with breathing difficulty, persistent vomiting preventing fluid intake, and signs of gallbladder problems require immediate medical attention. These serious side effects are rare but necessitate urgent clinical assessment.
Do side effects of Mounjaro differ from Wegovy or Saxenda?
The side effect profiles are similar across GLP-1 receptor agonists, with nausea and digestive symptoms being most common. Mounjaro may produce slightly lower nausea rates than equivalent doses of semaglutide, though individual responses vary significantly.
Will side effects of Mounjaro stop me from working or daily activities?
Most patients continue normal activities throughout treatment. Timing injections before weekends initially or scheduling them before bedtime helps manage any temporary symptoms without disrupting work or daily routines.
Can I stop Mounjaro immediately if side effects are too severe?
Yes, Mounjaro can be discontinued at any time without tapering, though you should consult your prescriber first. Many side effects improve with dose reduction rather than complete cessation, allowing continued treatment at a tolerable level.
Are there any long-term side effects of Mounjaro after years of use?
Clinical trials up to 52 weeks show no new safety concerns emerging with long-term use. Side effects typically decrease over time, and extended monitoring has not revealed unexpected risks in human populations beyond the initial safety profile.
Tarun Kumar, Prescribing Pharmacist

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Last reviewed: 28 July 2026